INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER

PR Newswire

NEW YORK, Feb. 25, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Pandion Therapeutics, Inc. (NASDAQ: PAND) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Merck for $60.00 per share in cash. If you are a Pandion shareholder, click here to learn more about your rights and options.  

PRA Health Sciences, Inc. (NASDAQ: PRAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to ICON plc. Under the terms of the transaction, PRA Health shareholders will receive $80.00 in cash and 0.4125 shares of ICON stock for each PRA Health share that they own. If you are a PRA Health shareholder, click here to learn more about your rights and options.  

Aegion Corporation (NASDAQ: AEGN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates of New Mountain Capital, L.L.C. for $26.00 per share in cash. If you are an Aegion shareholder, click here to learn more about your rights and options.  

Protective Insurance Corporation (NASDAQ: PTVCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Progressive Corporation for $23.30 in cash for each share of Protective Class A and Class B common stock. If you are a Protective shareholder, click here to learn more about your rights and options.  

CRH Medical Corporation (NYSE: CRHM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Well Health Technologies Corp. for $4.00 per share. If you are a CRH Medical shareholder, click here to learn more about your rights and options.  

Cleveland BioLabs, Inc. (NASDAQ: CBLI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Cytocom, Inc. Under the merger, Cleveland BioLabs stockholders are expected to own approximately 39% of the combined company. If you are a Cleveland BioLabs shareholder, click here to learn more about your rights and options. 

Akers Biosciences, Inc. (NASDAQ: AKER) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with MyMD Pharmaceuticals, Inc. If you are an Akers shareholder, click here to learn more about your legal rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected] 
[email protected]  
https://www.halpersadeh.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-investigates-the-following-companies-on-behalf-of-shareholders--pand-prah-aegn-ptvca-crhm-cbli-aker-301236207.html

SOURCE Halper Sadeh LLP

Copyright CNW Group 2021

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).